CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home›
Investors›
Cedas Foundation›
News
Cedas Foundation logo

Cedas Foundation

Operating Status: Operating

Cedas Foundation is an Isle of Man-based investment firm that backs seed-stage biotech and agri-food companies.

Location
Douglas, IM
Firm
Compare
Portfolio
Employees
News
Library

Latest News About Cedas Foundation

Hexafly emerges from SCARP rescue process

Business Plus

Hexafly emerges from SCARP rescue process

Hexafly completed a SCARP rescue arrangement in July 2023 after shareholders invested more than €4 million in the insect-protein venture;...

Jul 7, 2023

BioSapien Closes $1.8M Seed Round Led By SOSV & Hikma Ventures

Nasdaq

BioSapien Closes $1.8M Seed Round Led By SOSV & Hikma Ventures

BioSapien, a biotechnology company developing a 3D-printed biodegradable mesh drug-delivery platform, announced a $1.8 million seed round...

Nov 11, 2021

What SOSV's Climate Tech 100 tells founders about investors in the space

TechCrunch

What SOSV's Climate Tech 100 tells founders about investors in the space

An analysis of SOSV's Climate Tech 100 identified foundations and nonprofits as early-stage climate-tech backers, naming the CEDAS...

Jun 10, 2021

Hexaflying!

CapF9

Hexaflying!

CapF9 notes that Hexafly is now selling direct to market, supported by investors including the Cedas Foundation, a group of HBAN investors.

Jun 19, 2020

Irish start-up Hexafly looks to go global with insect farming

The Irish Times

Irish start-up Hexafly looks to go global with insect farming

Hexafly closed a €1.1 million funding round; other backers include SOSV, Yield Lab and Cedas Foundation.

Feb 4, 2019

Harvesting flies for protein: Hexafly secures another €1.1 million to feed fish and livestock

EU-Startups

Harvesting flies for protein: Hexafly secures another €1.1 million to feed fish and livestock

Irish agritech Hexafly raised a €1.1 million seed round to scale its black-soldier-fly protein production, with investors including...

Feb 4, 2019